Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKR) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Bruker (BRKR) over the last 16 years, with Q3 2025 value amounting to $1.2 billion.

  • Bruker's Treasury Shares rose 80.83% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year increase of 80.83%. This contributed to the annual value of $1.2 billion for FY2024, which is 0.0% changed from last year.
  • Bruker's Treasury Shares amounted to $31.0 million in Q3 2025, which was up 65.22% from $31.0 million recorded in Q2 2025.
  • Bruker's 5-year Treasury Shares high stood at $31.0 million for Q1 2025, and its period low was -$555576.0 during Q2 2021.
  • For the 5-year period, Bruker's Treasury Shares averaged around $20.6 million, with its median value being $28.7 million (2023).
  • Per our database at Business Quant, Bruker's Treasury Shares skyrocketed by 4342.23% in 2022 and then changed by 0.0% in 2024.
  • Over the past 5 years, Bruker's Treasury Shares (Quarter) stood at $820.3 million in 2021, then skyrocketed by 32.27% to $1.1 billion in 2022, then rose by 14.03% to $1.2 billion in 2023, then changed by 0.0% to $1.2 billion in 2024, then rose by 0.81% to $1.2 billion in 2025.
  • Its Treasury Shares stands at $1.2 billion for Q3 2025, versus $1.2 billion for Q4 2024 and $1.2 billion for Q3 2024.